Serotonin 1A receptors in the living brain of Alzheimer's disease patients - Wikidata - awgldk - TriplyDB

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

http://www.wikidata.org/entity/Q34271020

about

5-HT(1A) receptor function in major depressive disorder Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Current and future uses of neuroimaging for cognitively impaired patients.Tracking Alzheimer's disease.Differential FDDNP PET patterns in nondemented middle-aged and older adults Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination.Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹⁸F]mefway PET.Unveiling molecular events in the brain by noninvasive imaging.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions?Monte Carlo simulations of absorbed dose in a mouse phantom from 18-fluorine compounds.Functional expression of SGLTs in rat brain An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease.PET tracers for serotonin receptors and their applications Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.Postmortem 3-D brain hemisphere cortical tau and amyloid-β pathology mapping and quantification as a validation method of neuropathology imaging.Escitalopram attenuates β-amyloid-induced tau hyperphosphorylation in primary hippocampal neurons through the 5-HT1A receptor mediated Akt/GSK-3β pathway Protein binding in patients with late-life depression.The serotonergic system and cognitive function Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.Vascular risk and FDDNP-PET influence cognitive performance.Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.Does Alzheimer's disease begin in the brainstem?Epigenetic dysregulation of brainstem nuclei in the pathogenesis of Alzheimer's disease: looking in the correct place at the right time?Current therapeutic targets for the treatment of Alzheimer's disease.PET/CT in diagnosis of dementia Alzheimer's disease drug development: translational neuroscience strategies.Current status of positron emission tomography radiotracers for serotonin receptors in humans.Overview of experimental models of the blood-brain barrier in CNS drug discovery.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.The role of positron emission tomography imaging in understanding Alzheimer's disease.Neural correlates of apathy in late-life depression: a pilot [18 F]FDDNP positron emission tomography study.Monoaminergic neuropathology in Alzheimer's disease.

P2860

Q24643511-5A93EC75-B872-42BD-AC7B-A9A71496AAD0 Q26749755-0982DB1A-4F97-406B-996F-EA2D866D6CE0 Q27027221-6AF2DC69-4FE7-46FE-A979-AC0C4B50A4EA Q28066691-1D1FA286-3617-4BAE-ADA9-91297F933AF3 Q30724808-37F96E8D-02A2-4196-AB1E-3AFDB9C52F98 Q31047131-5325A691-45D5-42FE-8F14-7CB32C0361A4 Q31143267-80A96C5F-4EA2-4118-9FB0-22E9D4E51F68 Q33281339-7B1EAD37-D2CD-494E-B90A-A871D4042148 Q33899796-92BC2AE3-5AD5-4D7D-A26F-778F981DD460 Q34033357-D7C3F5C8-7135-4BAB-9133-87FE6354E71D Q34036060-CDF56DC7-4519-401B-821F-5C9808DDD8DB Q34046040-65D2B6C1-FA1A-4856-9B70-9773BFE7AAAC Q34078777-54CDE37B-6A0B-47E5-922A-CEC501C7F763 Q34200085-88E6EB61-81CA-4C87-87D1-3754F88E4206 Q34425601-0C493EE2-C853-4A5C-85F0-57721EC0C351 Q34426413-32597B4F-86E4-4E93-BE49-F0BBE249CD71 Q35037959-A1EA50F2-823C-463F-B8BF-F4DC13C43884 Q35090637-59000940-EFAD-4AC4-99D1-5470AEC17212 Q35446894-D81E0111-F124-4D64-9D5E-46AE3D06D7B7 Q35659141-E02C02E5-F0B6-4F90-AF52-5827EF0B3D06 Q35953886-3A5E19B7-4EF2-42B6-B11D-9A6BB28CD65F Q36724965-A91A5798-BBC5-41AE-910B-60AD30CD8649 Q36944895-58D80063-27E1-48C0-880D-EADD218B11A8 Q37046351-B5F5C705-4A0A-4F74-8722-6E13E8DEE6E9 Q37232088-D84CE617-FF49-4DEE-A0F8-054900969FA9 Q37245282-9DDBC6B5-8ED7-4397-98F7-21F0F2A0C8F2 Q37259576-9E0FB6EB-BFAA-43C6-9BD1-1D5136339D35 Q37417513-088F60E6-2F7D-44AF-A0DC-08B66FD9CE16 Q37445869-9C1310F2-63A1-40CC-B1D0-D3385F2D14F3 Q37456054-4C63314E-1047-445B-9B8E-09586C030F9F Q37590630-B1BE9FA2-CCB1-4DFD-9A2F-AD144F741E99 Q37737296-C051DAE0-153A-4EE6-86D8-BBEA5E57A810 Q37896141-5700A8D0-BDE3-46A5-B16D-2635858CD484 Q38087640-177DB716-C3C6-4B95-9C91-4BEC37724EEE Q38166965-F6703C26-55F2-441A-B57D-413D9100F5FD Q38186650-7D72FF5B-D10A-491D-8411-9EBA2C15EC8B Q38209851-C07E3E3E-0D70-490F-905E-87911F17780B Q38370609-4DA5083C-DC92-4874-A71E-A36B42AA2902 Q38764851-D34DC1EE-EF37-4D12-BFBA-54042DCDEC11 Q38809649-870EA8FA-4391-4DD9-8810-4BEA25BDE46A

P2860

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

http://www.wikidata.org/entity/Q34271020

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@ast

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@en

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@nl

type

label

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@ast

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@en

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@nl

prefLabel

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@ast

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@en

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@nl

P1433

Q34271020-8BF0D913-55A9-433B-9908-FCC228A7AFF7

P1476

Q34271020-5A1426F6-5BAC-40A9-BBBE-0B703919FB76

P2093

Q34271020-0268DD93-6F13-43C4-9495-F79136AF2072

Q34271020-1DBDA52C-FB07-4CBD-88E6-54D08266C3BD

Q34271020-1DED5D0E-A2D9-4E00-8E61-71C9CAB9C68D

Q34271020-3985DE63-A37D-43CE-AC39-6E037233DF21

Q34271020-4A302989-B39E-4EA1-822B-7CE3F6D80167

Q34271020-72247CF8-76EF-4396-9124-CCC514B9DF4B

Q34271020-A7CBB121-FF1A-4486-A6B3-2071BC323691

Q34271020-C1CB264B-CF8D-48D1-9EE2-39E44F161E29

Q34271020-C35537AD-FB1C-427E-9E5E-121A677A1616

Q34271020-E10F7A03-ACB2-4424-8BFD-78C959EAEDB8

P2860

Q34271020-059FDAE1-8EA0-42AD-9EC9-ACF085C0153E

Q34271020-0C6200C3-43B9-409C-81DA-57349B84D3E8

Q34271020-122BA81C-5A24-416C-9012-86EE2FD671D1

Q34271020-1D754D58-7BE5-4D69-8FB9-25F64790FFD5

Q34271020-21268C05-7F34-4C21-99DE-F0B71BD715C5

Q34271020-2DDD88AD-55AC-4B37-AF05-E2DB0AF10228

Q34271020-2F46A23A-F23C-480D-A891-32F491C30FC0

Q34271020-2F901DFC-A943-4157-9CEE-04B626A4F7B4

Q34271020-2FC7D572-CF42-4A1C-BDA9-B112DAF8DBA8

Q34271020-31E6DD60-7B11-4BED-A2FE-23E85186F2FD

P304

Q34271020-C48D994A-D747-421C-A294-2011FF356CDE

P31

Q34271020-8982BFCB-AAC6-4EF0-A193-CEC0B24F18B3

P356

Q34271020-98B49128-CA08-4384-AEFA-392BC0553CBB

P407

Q34271020-2A44A7E1-161C-42DD-9EA6-641EF1C81B05

P433

Q34271020-E9E549D5-EA35-4258-A0CA-23D3B7EE618C

P478

Q34271020-1CB3DF2E-A9CC-4A6B-A973-A2BD4837E9A0

P50

Q34271020-E385E2D5-34D8-497D-9E0F-B31574CF2B25

P577

Q34271020-A55AD094-AE39-4C46-B156-B2899CC86AF2

P5875

Q34271020-C3AD99E2-2BEB-4266-95F3-794630442FF0

P698

Q34271020-767858FA-BFC0-4EC3-AA99-589C8765C011

P921

Q34271020-2E8A1028-5711-400F-80F5-E8F6660619E8

Q34271020-4fd83343-0ff9-405a-978e-ccb15615cddf

Q34271020-F0ED9153-EA8E-468D-BF11-3595EEBD885A

P932

Q34271020-95AA880D-111A-414F-ACBF-6F4D343B709E

P356

PNAS.0510237103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Serotonin 1A receptors in the living brain of Alzheimer's disease patients

@en

P2093

Gary W Small

http://www.w3.org/2001/XMLSchema#string

Gregory M Cole

http://www.w3.org/2001/XMLSchema#string

Jorge R Barrio

http://www.w3.org/2001/XMLSchema#string

Kooresh Shoghi-Jadid

http://www.w3.org/2001/XMLSchema#string

Linda Ercoli

http://www.w3.org/2001/XMLSchema#string

Michael E Phelps

http://www.w3.org/2001/XMLSchema#string

Nagichettiar Satyamurthy

http://www.w3.org/2001/XMLSchema#string

Prabha Siddarth

http://www.w3.org/2001/XMLSchema#string

Sung-Cheng Huang

http://www.w3.org/2001/XMLSchema#string

Vladimir Kepe

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Neuropathological stageing of Alzheimer-related changes

Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635

Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.

Pyramidal cell axons show a local specialization for GABA and 5-HT inputs in monkey and human cerebral cortex.

Current concepts in mild cognitive impairment.

Quantitation in positron emission computed tomography: 1. Effect of object size.

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons.

P304

702-707

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0510237103

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Jeffrey L. Cummings

P577

2006-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7365167

http://www.w3.org/2001/XMLSchema#string

P698

16407119

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1334681

http://www.w3.org/2001/XMLSchema#string